Healthtech Startups

Kadis Bio develops human induced pluripotent stem cell (hiPSC) therapies for treating cardiovascular disease, targeting peripheral arterial disease and critical limb ischemia. Its approach aims to promote blood vessel growth for conditions such as ischemic heart disease, diabetic retinopathy and neuropathy, and wound healing.

1 investor

KAI provides AI-powered conversation analysis for pharmaceutical and healthcare professionals, using acoustic, linguistic, and visual intelligence to uncover emotional insights and improve communication between pharma field teams and healthcare providers, and between clinicians and patients.

1 investor

Elekta develops precision radiotherapy and radiosurgery systems for cancer treatment, including MR-guided and CT-guided adaptive radiotherapy and brachytherapy workflows. Its products serve clinicians and cancer treatment centers delivering personalized radiation therapy across a range of indications.

1 investor

Kailo Medical develops workflow automation and interoperable reporting systems for diagnostic imaging to reduce manual processes and improve clinician efficiency. The company serves radiology departments and healthcare providers globally.

1 investor

Kailos Genetics is a biotechnology company with expertise in medical and biotechnology industries.

1 investor

Kairos is a studio and incubator building a portfolio of consumer-focused companies designed to address major financial pain points for millennials and Gen Z, including housing, family planning, and healthcare. The organization invests in and operates brands across fintech, foodtech, healthtech, and proptech to make life more affordable and accessible.

1 investor

Kaiya provides peer-led support groups for teenagers focusing on mental wellbeing, offering evidence-based skills training and emotional support through trained peer support workers. The platform offers affordable group sessions starting at $19 and operates as a public benefit corporation serving teens across the United States.

1 investor

Kaizen offers an enterprise platform for health systems to centralize, manage, and enforce building design standards across capital projects. The platform replaces static PDFs and documents with a governed system of record that improves consistency, reduces rework, and accelerates project delivery.

1 investor

Modulus Housing is a factory-built prefabricated construction company that delivers industrialized micro-infrastructure solutions for rapid deployment across distributed locations in healthcare, food & beverage, EV charging, data centers, and other sectors. The company uses modular volumetric systems and flat-pack kits manufactured off-site to achieve faster project timelines, higher quality standardization, and lower costs compared to traditional on-site construction.

1 investor

Kalaris Therapeutics is a clinical-stage biopharmaceutical company developing treatments for prevalent retinal diseases such as wet AMD, diabetic eye disease, and retinal vein occlusion. Its lead asset is an engineered dual-targeting biologic aimed at longer-lasting anti-VEGF activity to reduce the frequency of injections for patients.

1 investor

Kalevala Therapeutics identifies drug repurposing opportunities for rare disease indications, aligning with clinical and advocacy partners to map regulatory pathways and pursue approval for new therapeutic uses. It operates in the biotech and drug development sector.

1 investor

KaliVir develops oncolytic virus immunotherapies for cancer treatment based on its Vaccinia Enhanced Template (VET) backbone, which uses proprietary genetic modifications to a vaccinia virus optimized for intravenous systemic delivery and expression of therapeutic transgenes within tumors. The technology targets tumor replication and metastatic spread while modulating anti-tumoral immunity.

1 investor

Kallik provides cloud-based labeling and artwork management software for highly regulated industries including medical devices, pharmaceuticals, chemicals, cosmetics, and food and beverage. The platform automates label and artwork creation, ensures regulatory compliance with audit trails, and reduces time to market.

1 investor

Kalohexis is a biopharmaceutical company developing treatments that target the melanocortin system, the body's regulator of metabolic homeostasis, to address metabolic disorders beginning with obesity and cancer cachexia. Its therapies aim to adjust the body's metabolic set-point for patients with metabolic disease.

1 investor

Kamada is a vertically integrated biopharmaceutical company that develops and manufactures plasma-derived therapeutics for specialty markets. The company commercializes its own branded products including GLASSIA and KEDRAB, as well as acquired hyperimmune products, distributing to over 30 countries globally.

1 investor

Kaminari Medical develops intravascular imaging technology for cardiovascular interventions, using photoacoustic and optical innovations. The company serves interventional cardiologists and vascular surgeons for real-time imaging during catheter-based procedures.

1 investor

Tunstall is a provider of health and social care services and technology solutions for elderly care and personal emergency response services across Europe and Asia-Pacific. The company serves healthcare providers, local governments, and individuals requiring care and safety services.

1 investor

Kando builds a unified platform that connects nurse-call systems, assistants, hardware, and software for care environments such as nursing homes and senior residences, aiming to reduce staff administrative workload and improve patient safety. It develops its own proprietary AI models, hardware, and software, operated in Europe with HDS hosting and GDPR compliance.

1 investor

Kannact is a human-driven digital health company that provides support services to help people achieve better health outcomes. The company focuses on patient engagement and care coordination for health improvement.

1 investor

Kantoko operates a telehealth platform connecting adults with ADHD specialists for remote diagnosis and treatment planning in Australia. The company aims to improve access to ADHD care by reducing wait times and costs while expanding into other healthcare specialties.

1 investor

Kanurra operates a transparent pharmacy benefit management (PBM) service for self-funded employers, charging a flat per-employee-per-month administrative fee while passing drug costs through at actual cost with full rebate transparency. The company eliminates hidden markups, retained rebates, and formulary kickbacks that characterize legacy PBMs.

1 investor

Karaz is an electronic health record (EHR) platform that connects health tools and continuous glucose monitor (CGM) devices to give healthcare practitioners real-time patient insights, biometrics, and analytics for personalized care. It also provides reporting, patient education, and regulatory compliance tools for medical practices.

1 investor

Kare Mobile operates a direct-to-consumer dental service delivery model through mobile units, aiming to increase access to oral healthcare across the country.

1 investor

KareInn provides digital care planning software for CQC-registered adult social care providers such as care homes, replacing paper-based care record processes with digital care records. It is an NHS Assured supplier operating in the UK adult social care sector.

1 investor